Ciproflox-dexameth otic susp 7.5ML
Ended Awarded
- Contract number
- SPE2DB25FR3BJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,191
Award facts
- Contract value 100% obligated
- $1,190.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) with a ceiling value of $1,190.89. This competitively awarded, firm fixed-price delivery order was executed on August 1, 2025, with an ultimate completion date of August 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX prime IDV functions as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen serves multiple federal customers, including the Defense Health Agency and U.S. Coast Guard, providing access to specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across numerous therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FR3BJ?
SPE2DB25FR3BJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FR3BJ worth?
The government has obligated $1,191 on SPE2DB25FR3BJ.
Is contract SPE2DB25FR3BJ an order under another contract?
Yes. SPE2DB25FR3BJ is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB25FR3BJ competed?
The extent of competition for SPE2DB25FR3BJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award